Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. Operating Income 2020–2023
Gain Therapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2023. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Gain Therapeutics Inc. operating income for the quarter ending March 31, 2023 was -5.2 M, a 59.03% increase year-over-year.
- Gain Therapeutics Inc. operating income for the twelve months ending March 31, 2023 was -18.3 M, a 149.97% increase year-over-year.
- Gain Therapeutics Inc. annual operating income for 2023 was -22.3 M, a 25.18% increase from 2022.
- Gain Therapeutics Inc. annual operating income for 2022 was -17.8 M, a 28.58% increase from 2021.
- Gain Therapeutics Inc. annual operating income for 2021 was -13.8 M, a 297.37% increase from 2020.
- Gain Therapeutics Inc. annual operating income for 2020 was -3.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Gain Therapeutics Inc. Operating Income — FAQ
Gain Therapeutics Inc. (GANX) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Gain Therapeutics Inc.'s operating income?
Gain Therapeutics Inc. (GANX) reported operating income of -$22M for fiscal 2023.
Where can I see GANX's operating income history?
The chart and table above show Gain Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.